The recent ARRA legislation provides an unprecedented level of funding ($8.2 billion in grant funding) to the NIH to help stimulate the US economy through the support and advancement of scientific research. While NIH Institutes and Centers have broad flexibility to invest in many types of grant programs, they will follow the spirit of the ARRA by funding projects that will stimulate the economy, create or retain jobs, and have the potential for making scientific progress in 2 years.
Learn More>>>

The Metabolic Disorders Steering Committee of The Biomarkers Consortium: Prioritized Areas of Unmet Medical Need

The Biomarkers Consortium is a major public-private biomedical research partnership, launched in October of 2006 by The Foundation for the National Institutes of Health (FNIH), the National Institutes of Health (NIH), the Food and Drug Administration (FDA), and the Pharmaceutical Research and Manufacturers of America (PhRMA).
Learn More>>>